Miles Levy

3.6k total citations
79 papers, 2.1k citations indexed

About

Miles Levy is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miles Levy has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Pathology and Forensic Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miles Levy's work include Pituitary Gland Disorders and Treatments (24 papers), Migraine and Headache Studies (14 papers) and Electrolyte and hormonal disorders (13 papers). Miles Levy is often cited by papers focused on Pituitary Gland Disorders and Treatments (24 papers), Migraine and Headache Studies (14 papers) and Electrolyte and hormonal disorders (13 papers). Miles Levy collaborates with scholars based in United Kingdom, United States and Australia. Miles Levy's co-authors include Peter J. Goadsby, Manjit Matharu, Karim Meeran, Yolande E. Knight, Thorsten Bartsch, Michael Powell, Trevor A. Howlett, Henrik Schumacher, Akhtar Husain and Hamidreza Mani and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Miles Levy

76 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miles Levy United Kingdom 24 816 677 631 367 286 79 2.1k
Pouneh K. Fazeli United States 34 287 0.4× 623 0.9× 226 0.4× 1.1k 3.0× 194 0.7× 93 3.6k
Laurent Maı̈moun France 27 247 0.3× 206 0.3× 412 0.7× 594 1.6× 69 0.2× 89 2.2k
Erinne Meenaghan United States 25 324 0.4× 299 0.4× 186 0.3× 312 0.9× 141 0.5× 43 1.8k
Ursula Wesselmann United States 26 883 1.1× 150 0.2× 103 0.2× 706 1.9× 271 0.9× 81 3.0k
Magdy Hassouna Canada 27 335 0.4× 130 0.2× 191 0.3× 286 0.8× 162 0.6× 132 3.8k
F Bernardi Italy 30 119 0.1× 854 1.3× 109 0.2× 230 0.6× 312 1.1× 90 2.7k
Fatih Tanrıverdi Türkiye 34 150 0.2× 2.1k 3.1× 137 0.2× 167 0.5× 169 0.6× 119 3.5k
Jan Verlooy Belgium 21 126 0.2× 469 0.7× 322 0.5× 144 0.4× 56 0.2× 43 1.9k
Franco Granella Italy 31 2.7k 3.3× 151 0.2× 2.0k 3.2× 1.2k 3.3× 47 0.2× 102 3.6k
Jody L. Clasey United States 23 157 0.2× 408 0.6× 153 0.2× 856 2.3× 36 0.1× 69 2.1k

Countries citing papers authored by Miles Levy

Since Specialization
Citations

This map shows the geographic impact of Miles Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles Levy more than expected).

Fields of papers citing papers by Miles Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miles Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles Levy. The network helps show where Miles Levy may publish in the future.

Co-authorship network of co-authors of Miles Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Miles Levy. A scholar is included among the top collaborators of Miles Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miles Levy. Miles Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russell, Richard, Syed F. Mohammad, Miles Levy, et al.. (2025). Assessment of an Oral Corticosteroid Withdrawal Pathway for Severe Asthma Patients Receiving Biologic Therapies. The Journal of Allergy and Clinical Immunology In Practice. 13(7). 1807–1815.e4.
2.
Levy, Miles, et al.. (2023). A case of primary adrenal hydatid cyst. Endocrine Abstracts. 1 indexed citations
3.
Arima, Hiroshi, Timothy Cheetham, Mirjam Christ‐Crain, et al.. (2022). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus. Hormone Research in Paediatrics. 96(4). 423–425. 2 indexed citations
4.
Arima, Hiroshi, Timothy Cheetham, Mirjam Christ‐Crain, et al.. (2022). Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. Archives of Endocrinology and Metabolism. 66(6). 868–870. 3 indexed citations
5.
Atila, Cihan, Aoife Garrahy, Bettina Winzeler, et al.. (2022). Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. The Lancet Diabetes & Endocrinology. 10(10). 700–709. 37 indexed citations
6.
Arima, Hiroshi, Timothy Cheetham, Mirjam Christ‐Crain, et al.. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocrine Journal. 69(11). 1281–1284. 6 indexed citations
7.
8.
Levy, Miles, Achim Berthele, Ichiro Nakashima, et al.. (2020). Efficacy and safety of eculizumab in patients with neuromyelitis optica spectrum disorder previously treated with rituximab: findings from PREVENT. Multiple Sclerosis Journal. 26. 1–1. 4 indexed citations
9.
Oreja‐Guevara, Celia, Jacqueline Palace, S J Pittock, et al.. (2020). Regional outcomes of eculizumab treatment in patients with aquaporin-4 immunoglobin G-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study. European Journal of Neurology. 27. 90–90. 1 indexed citations
10.
Berthele, Achim, S J Pittock, Miles Levy, et al.. (2019). Impact of eculizumab on reported quality of life in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the PREVENT study. Multiple Sclerosis Journal. 25. 294–295. 2 indexed citations
11.
Palace, Jacqueline, S J Pittock, Achim Berthele, et al.. (2019). Impact of eculizumab on disability measures in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: phase 3 PREVENT study. Multiple Sclerosis Journal. 25. 737–738. 1 indexed citations
12.
Levy, Miles, et al.. (2019). Diabetes insipidus. BMJ. 364. l321–l321. 11 indexed citations
13.
Gulsin, Gaurav S., et al.. (2016). Competing interests in a lung cancer with metastasis to the pituitary gland: syndrome of inappropriate ADH secretion versus diabetes insipidus. Oxford Medical Case Reports. 2016(6). 125–129. 5 indexed citations
14.
Levy, Miles, Olympia Koulouri, & Mark Gurnell. (2013). How to interpret thyroid function tests. Clinical Medicine. 13(3). 282–286. 31 indexed citations
15.
16.
Chahal, Harvinder, Karen Stals, Martina Unterländer, et al.. (2011). AIPMutation in Pituitary Adenomas in the 18th Century and Today. New England Journal of Medicine. 364(1). 43–50. 94 indexed citations
17.
Classey, J.D., et al.. (2005). No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours. Acta Neurologica Scandinavica. 111(5). 317–322. 14 indexed citations
18.
Levy, Miles, Hans Rolf Jäger, Michael Powell, et al.. (2004). Pituitary Volume and Headache. Archives of Neurology. 61(5). 721–721. 125 indexed citations
19.
Levy, Miles, Yolande E. Knight, C.T. O'Shaughnessy, & Peter J. Goadsby. (2003). Effect of IL-1β microinjection into the posterior hypothalamic area on trigeminal nociception in the rat. Journal of Neural Transmission. 110(12). 1349–1358. 1 indexed citations
20.
Levy, Miles, et al.. (2003). Somatostatin infusion withdrawal: a study of patients with migraine, cluster headache and healthy volunteers. Pain. 102(3). 235–241. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pouneh K. Fazeli Breakdown of academic impact, for papers by Laurent Maı̈moun Breakdown of academic impact, for papers by Erinne Meenaghan Breakdown of academic impact, for papers by Ursula Wesselmann Breakdown of academic impact, for papers by Magdy Hassouna Breakdown of academic impact, for papers by F Bernardi Breakdown of academic impact, for papers by Fatih Tanrıverdi Breakdown of academic impact, for papers by Jan Verlooy Breakdown of academic impact, for papers by Franco Granella Breakdown of academic impact, for papers by Jody L. Clasey
Rankless by CCL
2026